Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 4:27 pm Purchase | 2023-02-07 | 13D | Avalo Therapeutics, Inc. AVTX | Armistice Capital, LLC | 19,928 35.400% | 1,876 (+10.39%) | Filing History |
| 2022-09-23 1:40 pm Purchase | 2022-09-23 | 13G | Freshpet, Inc. FRPT | Armistice Capital, LLC | 2,650,000 5.500% | 2,650,000 (New Position) | Filing History |
| 2022-08-11 4:09 pm Sale | 2022-08-08 | 13D | Avalo Therapeutics, Inc. AVTX | Armistice Capital, LLC | 18,052 44.400% | -0 (-0.00%) | Filing History |
| 2022-06-21 06:08 am Unchanged | 2022-06-21 | 13G | Tenax Therapeutics, Inc. TENX | Armistice Capital, LLC | 1,608 9.990% | 0 (Unchanged) | Filing History |
| 2022-06-17 5:16 pm Purchase | 2022-06-10 | 13D | Tenax Therapeutics, Inc. TENX | Armistice Capital, LLC | 1,608 9.990% | 0 (+0.02%) | Filing History |
| 2022-05-20 4:52 pm Unchanged | 2022-05-17 | 13D | Tenax Therapeutics, Inc. TENX | Armistice Capital, LLC | 1,608 9.990% | 0 (Unchanged) | Filing History |
| 2022-03-15 5:16 pm Purchase | 2022-03-14 | 13D | Avalo Therapeutics, Inc. AVTX | Armistice Capital, LLC | 18,052 44.500% | 408 (+2.31%) | Filing History |
| 2022-02-14 9:56 pm Sale | 2021-12-31 | 13G | Vanda Pharmaceuticals Inc. VNDA | Armistice Capital, LLC | 0 0.000% | -5,399,277 (Position Closed) | Filing History |
| 2022-02-14 9:55 pm Sale | 2021-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS | Armistice Capital, LLC | 0 0.000% | -2,742,000 (Position Closed) | Filing History |
| 2022-02-14 9:54 pm Sale | 2021-12-31 | 13G | Voyager Therapeutics, Inc. VYGR | Armistice Capital, LLC | 0 0.000% | -3,392,000 (Position Closed) | Filing History |
| 2022-02-14 9:37 pm Purchase | 2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Armistice Capital, LLC | 800,000 5.100% | 800,000 (New Position) | Filing History |
| 2022-02-14 7:10 pm Sale | 2021-12-31 | 13G | BIOLASE, Inc. BIOL | Armistice Capital, LLC | 0 0.000% | -2,872 (Position Closed) | Filing History |
| 2022-02-14 7:03 pm Purchase | 2021-12-31 | 13G | Supernus Pharmaceuticals, Inc. SUPN | Armistice Capital, LLC | 4,136,000 7.800% | 1,016,000 (+32.56%) | Filing History |
| 2022-02-14 7:01 pm Sale | 2021-12-31 | 13G | Lantheus Holdings, Inc. LNTH | Armistice Capital, LLC | 0 0.000% | -5,200,000 (Position Closed) | Filing History |
| 2022-02-14 6:48 pm Purchase | 2021-12-31 | 13G | XTI Aerospace, Inc. XTIA | Armistice Capital, LLC | 7 9.990% | 7 (New Position) | Filing History |
| 2022-02-14 6:46 pm Purchase | 2021-12-31 | 13G | Conformis, Inc. CFMS | Armistice Capital, LLC | 480,000 6.100% | 98,466 (+25.81%) | Filing History |
| 2022-02-14 6:44 pm Sale | 2021-12-31 | 13G | Citius Pharmaceuticals, Inc. CTXR | Armistice Capital, LLC | 97,000 1.600% | -149,734 (-60.69%) | Filing History |
| 2022-02-14 6:43 pm Purchase | 2021-12-31 | 13G | Scopus BioPharma Inc. SCPS | Armistice Capital, LLC | 2,100,000 9.960% | 2,100,000 (New Position) | Filing History |
| 2022-02-14 6:43 pm Purchase | 2021-12-31 | 13G | AcelRx Pharmaceuticals, Inc. ACRX | Armistice Capital, LLC | 615,724 9.990% | 615,724 (New Position) | Filing History |
| 2022-02-14 6:42 pm Purchase | 2021-12-31 | 13G | ReWalk Robotics Ltd. LFWD | Armistice Capital, LLC | 378,686 4.100% | 179,408 (+90.03%) | Filing History |